It is true that the title Covid-19 has lost interest in the online sphere, but the number is high and the world remains an epidemic. The U.S. Pharmaceuticals Agency (FDA) has now stated that the Pfizer vaccine is safe and effective for children under 5 years of age after vaccinating adults.
Under the proposed scheme, the first two doses of Pfizer would be given at three-week intervals, and the third second dose eight weeks later.
The FDA plans a meeting of experts next Wednesday (15) to decide whether to recommend the Pfizer vaccine (given in three doses for children aged six months to five years) and the modern vaccine (two doses). For children from six months to five years).
According to the FDA, in the United States and most countries, only children under the age of five who are not yet eligible for the COV-19 vaccine are hospitalized, and their mortality rate is “higher than in other countries.” Children and adolescents. 5 to 17 years.
Preliminary estimates put the vaccine’s effectiveness at 80.3%, but the FDA noted that this percentage was based on a few positive events – just 10 compared to the 21 requested for a more accurate estimate.
There are 20 million American children under the age of five, which is 6% of the population.
As expected, if FDA-appointed experts recommend both vaccines, the matter immediately moves to another panel convened by the Center for Disease Control and Prevention (CDC), which will have the final say.
Last week, White House officials announced that the release of millions of doses of these vaccines could begin on June 21 in the offices of pharmacies and doctors.
“Music geek. Coffee lover. Devoted food scholar. Web buff. Passionate internet guru.”